Observational Study of Pain Reduction in Late-Stage Cancer Patients Who Are Receiving Low-Dose Chemotherapy
1 other identifier
observational
300
0 countries
N/A
Brief Summary
Observational Study of Pain Reduction in Late Stage Cancer Patients Receiving Low-Dose Chemotherapy
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2015
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2015
CompletedFirst Submitted
Initial submission to the registry
May 2, 2015
CompletedFirst Posted
Study publicly available on registry
May 14, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2020
CompletedMay 14, 2015
May 1, 2015
5.3 years
May 2, 2015
May 13, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
Pain Level Self Assessment
From enrollment in study to termination of study (August 2020)
5 years
Eligibility Criteria
Patients Receiving Low Dose Chemotherapy
You may qualify if:
- Patient requests to be included in this study
You may not qualify if:
- Patient does not request to be included in this study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
gary l smith, mba
Cure Cancer Worldwide, LLC
Study Design
- Study Type
- observational
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 2, 2015
First Posted
May 14, 2015
Study Start
May 1, 2015
Primary Completion
August 1, 2020
Study Completion
December 1, 2020
Last Updated
May 14, 2015
Record last verified: 2015-05